Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Intranasal Corticosteroids Market Valued at Present and by 2029?

In recent times, the intranasal corticosteroids market has seen a robust expansion. By 2025, it is predicted to grow from $6.29 billion in 2024 to $6.78 billion, indicating a compound annual growth rate (CAGR) of 7.8%. The substantial growth in the historical period points to several factors, such as the increasing instances of allergic rhinitis, the rising occurrence of chronic sinusitis, amplified awareness about non-oral treatment alternatives, escalating use for treating pediatric allergic ailments, and the growing availability of over-the-counter intranasal products.

The market size of intranasal corticosteroids is forecasted to experience robust expansion in the coming years, with an expected value of $9.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.6%. Various factors likely to drive growth during the forecast period include a growing emphasis on minimally invasive treatments, an increase in allergic diseases due to climate fluctuations, a rising preference for self-managed therapies, an expanded use of combined intranasal treatments, and increased reliance on digital health aids for allergy management. Key trends to watch during this period include the use of smart devices for dosage tracking, innovations in preservative-free nose sprays, the development of child-friendly formulations, the devise of steroid-free additional therapies, and the unification of e-health channels for managing treatment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25799&type=smp

#What Drivers Are Influencing Growth In The Intranasal Corticosteroids Market?

Rising instances of allergic rhinitis are poised to fuel the expansion of the intranasal corticosteroids market in the future. Allergic rhinitis, an inflammation of the nasal passages induced by an allergy, is usually set off by allergens in the air such as pollen, dust mites, mold, or animal dander. The escalation in allergic rhinitis cases is chiefly attributed to increasing pollution, which exposes individuals to airborne allergens and irritants causing allergic reactions in the nasal passages. Intranasal corticosteroids aid in managing allergic rhinitis by reducing the inflammation in nasal passages, thereby reducing symptoms such as sneezing, congestion, and a runny nose. For example, in October 2023, as per the National Library of Medicine, a U.S.-based biomedical library, allergic rhinitis reportedly affects over 400 million people globally, with rates predicted to be 10% to 30% among adults and exceeding 40% in children. Thus, the escalating prevalence of allergic rhinitis is propelling the growth of the intranasal corticosteroid market.

What Are The Main Segments Identified In The Intranasal Corticosteroids Market Research?

The intranasal corticosteroids market covered in this report is segmented –

1) By Drug Types: Prescribed Drugs, Over-The-Counter Drugs

2) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel

4) By End User: Hospitals, Clinics, Homecare, Healthcare Providers

Subsegments:

1) By Prescribed Drugs: Fluticasone Propionate, Mometasone Furoate, Budesonide, Beclomethasone Dipropionate, Ciclesonide

2) By Over-The-Counter Drugs: Triamcinolone Acetonide, Fluticasone Furoate, Budesonide Over-The-Counter Drugs

What Are The Leading Trends And Opportunities In The Intranasal Corticosteroids Sector?

Leading firms in the intranasal corticosteroids market are concentrating on the creation of cutting-edge formulations like nasal sprays to boost targeted delivery and increase patient adherence. Nasal sprays serve as liquid remedies introduced directly into the nose via a spray nozzle to address issues such as allergies, congestion, and inflammation. These sprays enable swift drug absorption through the nasal mucosa, providing immediate relief with little systemic impacts. For instance, in March 2024, OptiNose Inc., a pharmaceutical company based in the US, was granted approval from the U.S. Food and Drug Administration (FDA) for XHANCE, the premier treatment expressly designed for adults afflicted with chronic rhinosinusitis (CRS) sans nasal polyps. This specific nasal spray applies an innovative exhalation delivery system which allows the drug to penetrate deeply into the nasal cavity, effectively tackling CRS with or without nasal polyps in adults. Each spray dispenses 93 mcg of fluticasone propionate, and the device functions by the user exhaling into a mouthpiece while concurrently discharging the spray into the nostril, affirming precise delivery and superior symptom alleviation.

Which Companies Play A Key Role In The Development Of The Intranasal Corticosteroids Market?

Major companies operating in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/intranasal-corticosteroids-global-market-report

What Are The Key Regional Developments Shaping The Intranasal Corticosteroids Market?

North America was the largest region in the intranasal corticosteroids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intranasal corticosteroids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25799&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model